Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Tumor Response Assessment in Metastatic Breast Cancer Involving Bones

NCT00420433 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00420433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00420433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Tumor Response Assessment in Metastatic Breast Cancer Involving Bones
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2004
Completion date
May 31, 2012
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast cancer